Search

everythinglearnresearchcommunity

for

Search:↓

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

SHBG may be a useful early indicator and treatment target for PCOS.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Some skin diseases and their treatments can negatively affect male fertility.

Treating PCOS is complex, involving medication like metformin and lifestyle changes, and requires attention to mental health due to high depression and anxiety rates.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

PCOS women with COVID-19 have higher cardiometabolic risks.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

The metoprolol-spironolactone combination improves heart function in patients with coronary heart disease and heart failure.

Skin issues in PCOS worsen quality of life and are linked to hormonal imbalances.

A girl with rickets and hair loss was found to have a rare condition where her body didn't respond to vitamin D treatment.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The document concludes that more research is needed to fully understand the causes of PCOS.